Biomark Diagnostics Inc

NEW
STU:20B (Canada)  
€ 0.32 (0%) Jul 31
At Loss
P/B:
186.67
Market Cap:
€ 36.45M ($ 42.05M)
Enterprise V:
€ 36.27M ($ 41.84M)
Volume:
0
Avg Vol (2M):
25.00
Trade In:

Biomark Diagnostics Inc (STU:20B) Dividend

Biomark Diagnostics Inc (STU:20B) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -8.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:20B Dividend

Does Biomark Diagnostics Inc (STU:20B) pay a dividend?

Biomark Diagnostics Inc (STU:20B) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Biomark Diagnostics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Biomark Diagnostics Inc has returned capital to shareholders via buybacks at a rate of -8.1% over the past 3 years.

What are dividend-paying alternatives to Biomark Diagnostics Inc?

For dividend-paying alternatives in Biomark Diagnostics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.